Country: Australia
Bahasa: Inggeris
Sumber: Department of Health (Therapeutic Goods Administration)
omeprazole, Quantity: 2 mg/mL
Boucher & Muir Pty Ltd
Suspension, powder for
Excipient Ingredients: sodium bicarbonate; potassium bicarbonate; sodium alginate; mannitol; sucralose; xanthan gum; sodium benzoate; sodium methyl hydroxybenzoate; maltitol; titanium dioxide; Flavour
Oral
75 mL
(S4) Prescription Only Medicine
Omeprazole ADVZ is indicated for:- Adults -Treatment of duodenal ulcers - Prevention of relapse of duodenal ulcers - Treatment of gastric ulcers - Prevention of relapse of gastric ulcers - In combination with appropriate antibiotics, Helicobacter pylori (H. pylori) eradication in peptic ulcer disease - Treatment of NSAID-associated gastric and duodenal ulcers - Prevention of NSAID-associated gastric and duodenal ulcers in patients at risk - Treatment of reflux oesophagitis - Long-term management of patients with healed reflux oesophagitis - Treatment of symptomatic gastro-oesophageal reflux disease (GORD) Paediatric use Children over 1 month of age - Treatment of reflux oesophagitis - Symptomatic treatment of heartburn and acid regurgitation in GORD Children over 4 years of age and adolescents In combination with antibiotics in treatment of duodenal ulcer caused by H. pylori
Visual Identification: White/off white/slightly yellow powder; Container Type: Bottle; Container Material: Polyethylene Terephthalate; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Registered
2023-04-28